.jpg "Øyvind S. Bruland, MD PhD photo")
Professor of Clinical Oncology
Oslo University Hospital, Norway
Professor of Clinical Oncology (Tenure position), University of Oslo, Norway & Senior Consultant Oncologist, Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Norway
The total number of publications during the career: 226 papers. H-Index: 40. Citations: 7810 (without self-citations). Source: ISI Web of Science, April 2022.
Five publications from the last ten years with the highest number of their citations:
1. C. Parker, S. Nilsson, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med 2013; 369: 213-223. Citations: 1467.
2. O. Sartor, R. Coleman, et al. Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial. Lancet Oncol 2014; 15: 738-746. Citations: 257.
3. S. Nilsson, P. Strang, et al. A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. Eur J Cancer 2012; 48: 678-686. Citations: 157.
4. S. Nilsson, S. Franzen, et al. Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases. Clin Genitourin Cancer 2013; 11:20-26. Citations: 77.
5. K. Berner, T. B. Johannesen, et al. Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma. Acta Oncol 2015; 54:25-33. Citations: 50.